Lincoln Pharmaceuticals Limited (LINCOLN.NS) NSE
591.70
+1.7(+0.29%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.32B |
| Enterprise Value | 11.03B |
| P/E Ratio | 13.34 |
| PEG Ratio | 1.98 |
| Price/Sales Ratio | 1.75 |
| Price/Book Ratio | 1.55 |
| Enterprise/Revenue | 1.71 |
| Enterprise/EBITDA | 9.52 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.12 |
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 6.71B |
| Revenue/Share | 335.1 |
| Gross Profit | 2.2B |
| EBITDA | 976.84M |
| Net Income | 878.94M |
| Diluted EPS | 43.88 |
Balance Sheet
| Total Cash | 2.41B |
| Total Cash/Share | 120.45 |
| Total Debt | 44.22M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.25 |
| Book Value Per Share | 378.34 |
Price History
| 52-Week Change | 6.95 |
| 52-Week High | 770 |
| 52-Week Low | 440 |
| Moving Average 50 Days | 634.49 |
| Moving Average 200 Days | 556.93 |
Statistics
| Average Volume | 156,408 |
| Shares Outstanding | 20.03M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.8 |
| Trailing Annual Dividend Yield | 0.31 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
